SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-018793
Filing Date
2023-06-28
Accepted
2023-06-28 17:11:31
Documents
101
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K vtgn20230331_10k.htm   iXBRL 10-K 2588397
2 EXHIBIT 10.159 ex_537095.htm EX-10.159 10520
3 EXHIBIT 10.161 ex_537096.htm EX-10.161 47709
4 EXHIBIT 10.162 ex_537097.htm EX-10.162 10174
5 EXHIBIT 21.1 ex_536705.htm EX-21.1 1767
6 EXHIBIT 23.1 ex_536704.htm EX-23.1 2332
7 EXHIBIT 31.1 ex_536703.htm EX-31.1 8752
8 EXHIBIT 31.2 ex_536702.htm EX-31.2 8759
9 EXHIBIT 32.1 ex_536701.htm EX-32.1 4401
15 img03.jpg GRAPHIC 165710
16 img04.jpg GRAPHIC 144354
17 img05.jpg GRAPHIC 180053
18 img07.jpg GRAPHIC 91462
19 slide02.jpg GRAPHIC 69674
  Complete submission text file 0001437749-23-018793.txt   13593939

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20230331.xsd EX-101.SCH 93251
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20230331_cal.xml EX-101.CAL 63160
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20230331_def.xml EX-101.DEF 639026
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20230331_lab.xml EX-101.LAB 502117
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20230331_pre.xml EX-101.PRE 670077
95 EXTRACTED XBRL INSTANCE DOCUMENT vtgn20230331_10k_htm.xml XML 1770683
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-37761 | Film No.: 231053123
SIC: 2834 Pharmaceutical Preparations